2026-02-11——
Thermo Fisher Scientific and Datavant announce strategic data collaboration on RWD linkage
A short entry: a summary of the public record, checked against its sources, not yet read and analysed by Gianluca. How the register works
Thermo Fisher Scientific announced on 11 February 2026 a strategic data collaboration with Datavant to integrate Datavant's tokenization and linkage technology into Thermo Fisher's PPD clinical research business, enabling it to securely connect de-identified research datasets and retrieve consented EMR data for bespoke RWD generation.
What happened
- Announced 11 February 2026 from Waltham, Mass.
- Datavant's encrypted token technology will be integrated across RWD enrichment of randomized clinical trials, PPD CorEvitas Clinical Registries and PPD Evidera solutions.
- Datavant enables privacy-preserving tokenization and linkage across more than 350 RWD partners and 80,000 U.S. hospitals and clinics.
- Datavant enables more than 60 million healthcare records to move between thousands of organizations across the healthcare ecosystem.
- The collaboration builds on Thermo Fisher's broader investments in digital innovation, including its strategic collaboration with OpenAI.
- Executives quoted: Karen Kaucic (president, patient and advisory services, and CMO, clinical research, Thermo Fisher), Krishna Cheriath (VP, head of digital and AI, biopharma services, Thermo Fisher), and Arnaub Chatterjee (GM and President of Life Sciences, Datavant).
Sources
- datavant.com — primary
Announced 2026-02-11